Korea Investment CORP Sells 4,600 Shares of DaVita Inc. (NYSE:DVA)

Korea Investment CORP lessened its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 15.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,019 shares of the company's stock after selling 4,600 shares during the quarter. Korea Investment CORP's holdings in DaVita were worth $3,742,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund bought a new position in shares of DaVita in the fourth quarter valued at about $449,000. Financial Engines Advisors L.L.C. grew its stake in DaVita by 2.7% in the 4th quarter. Financial Engines Advisors L.L.C. now owns 15,112 shares of the company's stock valued at $2,260,000 after buying an additional 403 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp raised its holdings in DaVita by 15.3% in the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 128,528 shares of the company's stock valued at $19,221,000 after acquiring an additional 17,008 shares during the period. Del Sette Capital Management LLC acquired a new stake in DaVita during the fourth quarter worth approximately $1,254,000. Finally, KLP Kapitalforvaltning AS bought a new stake in shares of DaVita during the fourth quarter worth approximately $4,234,000. Institutional investors own 90.12% of the company's stock.

DaVita Price Performance

DVA traded down $4.37 on Friday, hitting $149.37. 1,009,511 shares of the stock were exchanged, compared to its average volume of 810,838. The firm has a market capitalization of $11.95 billion, a price-to-earnings ratio of 13.91, a PEG ratio of 1.07 and a beta of 1.04. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The business has a 50-day moving average of $156.16 and a two-hundred day moving average of $157.39.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Sell-side analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analyst Weigh In

DVA has been the subject of several research reports. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. Cowen reissued a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. StockNews.com downgraded shares of DaVita from a "buy" rating to a "hold" rating in a research note on Wednesday. Finally, Barclays lifted their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.